Enanta Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 70 U.S.-traded ETFs. ENTA has around 3.2M shares in the U.S. ETF market. The largest ETF holder of ENTA is the iShares Core S&P Small-Cap ETF (IJR), with approximately 1.00M shares. Investors may also find of interest that the ETF with the largest allocation to ENTA stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 2.07%. On average, U.S. ETFs allocate 0.19% of ENTA to their portfolios.
Additionally, ENTA is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ENTA as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 46.99%.